TET2 gene
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| TET2 | associated_with | acute myeloid leukemia | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Variant interpretation using population databases: Lessons from gnomAD. (2022)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- PGBD5 promotes site-specific oncogenic mutations in human tumors. (2017)
- Detectable clonal mosaicism from birth to old age and its relationship to cancer. (2012)
- EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. (1998)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tet2 | gene | 22 | 47 |